SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00
http://www.w3.org/2000/01/rdf-schema#comment
"Results demonstrate that NR2F6 promotes the stem cell-like phenotype and induces cisplatin resistance in epithelial ovarian cancer (EOC) cells by activating the Notch3 pathway."
xsd:string
http://purl.uniprot.org/uniprot/#_ECF6D47CFD68982CF88BA021A74C2B7721C6969BFF3A0AC4B8EAE28CF021E345E32ADF0DA5C160F1D3A97E1233726E7C
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00
http://purl.uniprot.org/uniprot/F1D8R3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00
http://purl.uniprot.org/uniprot/#_F1D8R3-mappedCitation-30895619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2412376F64CD58906F7FF5EC4790B69182ECA2FA12B426BD25A58C7C674F5D8D208703CBEA4F1E8517F991A374351F00